首页 > 最新文献

Iranian Journal of Pharmaceutical Research最新文献

英文 中文
A Lead Target Molecule for Excisional Wound Healing: Trypthantrin Compound. 切除性伤口愈合的主要靶分子:色氨酸化合物。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-12-01 DOI: 10.5812/ijpr-127665
Zerrin Kutlu, Zekai Halici, Semin Gedikli, Busra Diyarbakir, Maide Sena Civelek

Objectives: We aimed to evaluate the impact of the tryptanthrin (TRP) compound, with antimicrobial and anti-inflammatory effects, on the excisional wound (EW) model. In an EW model in mice, we tried to explain the possible effect of TRP through vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) that contribute significantly to wound healing.

Methods: A total of 90 BALB-C female mice aged 6 - 8 weeks were used in the present study. Animals were randomly divided into five groups. After creating the EW model, three different doses (1, 2.5, 5 mg/kg) of TRP compound were applied topically for 14 days, and wound closure rates were measured on days 0, 3, and 7. Vascular endothelial growth factor and MMP-9 were evaluated on days 3, 7, and 14 on wound explants and on day 14 on serum samples by enzyme-linked immunosorbent assay. Histopathological analysis was performed on wound explants.

Results: After the EW model creation, significant healing of the wound areas was observed in the groups for which TRP was applied, especially on the third day. Moreover, in groups that received the third dose of TRP, the wound closure rate was 94%. It was found that the wound areas were closed due to the increase in TRP dose. In line with wound healing, VEGF and MMP-9 levels gradually rose on the third and seventh days and decreased on the 14th day.

Conclusions: Tryptanthrin compound usage on the EW model increased wound healing and did not leave a scar after 14 days.

目的:评价具有抗菌和抗炎作用的色胺氰苷(TRP)化合物对切除创面(EW)模型的影响。在小鼠EW模型中,我们试图通过血管内皮生长因子(VEGF)和基质金属蛋白酶-9 (MMP-9)来解释TRP对伤口愈合的可能作用。方法:选用6 ~ 8周龄BALB-C雌性小鼠90只。动物被随机分为五组。制作EW模型后,局部应用三种不同剂量(1、2.5、5 mg/kg)的TRP化合物14天,并在第0、3、7天测量伤口愈合率。分别于第3、7、14天和第14天用酶联免疫吸附法检测创面外植体和血清样品中血管内皮生长因子和MMP-9的含量。对创面植体进行组织病理学分析。结果:在EW模型制作后,TRP组创面愈合明显,特别是在第3天。此外,在接受第三剂量TRP的组中,伤口愈合率为94%。结果发现,由于TRP剂量的增加,创面闭合。随着创面愈合,VEGF和MMP-9水平在第3天和第7天逐渐升高,第14天下降。结论:复方色氨酸对EW模型的创面愈合有促进作用,14天后无瘢痕形成。
{"title":"A Lead Target Molecule for Excisional Wound Healing: Trypthantrin Compound.","authors":"Zerrin Kutlu,&nbsp;Zekai Halici,&nbsp;Semin Gedikli,&nbsp;Busra Diyarbakir,&nbsp;Maide Sena Civelek","doi":"10.5812/ijpr-127665","DOIUrl":"https://doi.org/10.5812/ijpr-127665","url":null,"abstract":"<p><strong>Objectives: </strong>We aimed to evaluate the impact of the tryptanthrin (TRP) compound, with antimicrobial and anti-inflammatory effects, on the excisional wound (EW) model. In an EW model in mice, we tried to explain the possible effect of TRP through vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) that contribute significantly to wound healing.</p><p><strong>Methods: </strong>A total of 90 BALB-C female mice aged 6 - 8 weeks were used in the present study. Animals were randomly divided into five groups. After creating the EW model, three different doses (1, 2.5, 5 mg/kg) of TRP compound were applied topically for 14 days, and wound closure rates were measured on days 0, 3, and 7. Vascular endothelial growth factor and MMP-9 were evaluated on days 3, 7, and 14 on wound explants and on day 14 on serum samples by enzyme-linked immunosorbent assay. Histopathological analysis was performed on wound explants.</p><p><strong>Results: </strong>After the EW model creation, significant healing of the wound areas was observed in the groups for which TRP was applied, especially on the third day. Moreover, in groups that received the third dose of TRP, the wound closure rate was 94%. It was found that the wound areas were closed due to the increase in TRP dose. In line with wound healing, VEGF and MMP-9 levels gradually rose on the third and seventh days and decreased on the 14th day.</p><p><strong>Conclusions: </strong>Tryptanthrin compound usage on the EW model increased wound healing and did not leave a scar after 14 days.</p>","PeriodicalId":14595,"journal":{"name":"Iranian Journal of Pharmaceutical Research","volume":"21 1","pages":"e127665"},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d1/0b/ijpr-21-1-127665.PMC10024809.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9158588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis and Biological Evaluation of Novel Anti-leukemia Proteolysis-Targeting Chimeras in Degradating Inosine Monophosphate Dehydrogenase. 新型抗白血病蛋白降解单磷酸肌苷脱氢酶嵌合体的合成及生物学评价。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-12-01 DOI: 10.5812/ijpr-129251
Hamidreza Sohbati, Mohsen Amini, Saeed Balalaie

Background: Proteolysis-targeting chimera (PROTAC) is a bifunctional molecule comprising a ligand to recognize the targeted protein to be degraded.

Objectives: To use the advantages of the PROTAC technique, we have synthesized novel compounds to degrade inosine monophosphate dehydrogenase (IMPDH) by the proteasome system.

Methods: We describe the synthesis of new PROTACs based on a combination of mycophenolic acid (MPA) as the potent IMPDH inhibitor and pomalidomide as a ligand of E3 ubiquitin ligase via linkers formed from Cu(I)-catalyzed cycloaddition reaction.

Results: All synthesized compounds were investigated against Jurkat cells as acute T-cell leukemia and were potent apoptosis inducers at 50 nM.

Conclusion: The effect of compound 2 in 0.05 μM on IMPDH degradation can be almost prevented by competition with bortezomib as the proteasome inhibitor at 0.1 and 0.5 μM.

背景:蛋白水解靶向嵌合体(Proteolysis-targeting chimera, PROTAC)是一种双功能分子,由一个配体组成,可以识别被降解的目标蛋白。目的:利用PROTAC技术的优势,合成了蛋白酶体系统降解肌苷一磷酸脱氢酶(IMPDH)的新化合物。方法:以霉酚酸(MPA)作为有效的IMPDH抑制剂,泊马度胺作为E3泛素连接酶的配体,通过Cu(I)催化的环加成反应形成的连接体,合成了新的PROTACs。结果:合成的化合物对Jurkat细胞急性t细胞白血病均有抑制作用,在50 nM下均有诱导细胞凋亡的作用。结论:化合物2在0.05 μM范围内与硼替佐米在0.1 μM和0.5 μM范围内作为蛋白酶体抑制剂竞争,几乎可以抑制其对IMPDH的降解作用。
{"title":"Synthesis and Biological Evaluation of Novel Anti-leukemia Proteolysis-Targeting Chimeras in Degradating Inosine Monophosphate Dehydrogenase.","authors":"Hamidreza Sohbati,&nbsp;Mohsen Amini,&nbsp;Saeed Balalaie","doi":"10.5812/ijpr-129251","DOIUrl":"https://doi.org/10.5812/ijpr-129251","url":null,"abstract":"<p><strong>Background: </strong>Proteolysis-targeting chimera (PROTAC) is a bifunctional molecule comprising a ligand to recognize the targeted protein to be degraded.</p><p><strong>Objectives: </strong>To use the advantages of the PROTAC technique, we have synthesized novel compounds to degrade inosine monophosphate dehydrogenase (IMPDH) by the proteasome system.</p><p><strong>Methods: </strong>We describe the synthesis of new PROTACs based on a combination of mycophenolic acid (MPA) as the potent IMPDH inhibitor and pomalidomide as a ligand of E3 ubiquitin ligase via linkers formed from Cu(I)-catalyzed cycloaddition reaction.</p><p><strong>Results: </strong>All synthesized compounds were investigated against Jurkat cells as acute T-cell leukemia and were potent apoptosis inducers at 50 nM.</p><p><strong>Conclusion: </strong>The effect of compound 2 in 0.05 μM on IMPDH degradation can be almost prevented by competition with bortezomib as the proteasome inhibitor at 0.1 and 0.5 μM.</p>","PeriodicalId":14595,"journal":{"name":"Iranian Journal of Pharmaceutical Research","volume":"21 1","pages":"e129251"},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6a/9e/ijpr-21-1-129251.PMC10024327.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9163588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential Benefits of Aloe vera and Raphanus sativus var. longipinnatus Gel for Prevention of Radiation-Induced Dermatitis in Head and Neck Cancer Patients. 芦荟和长鼻莴苣凝胶预防头颈癌患者放射性皮炎的潜在益处。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-12-01 DOI: 10.5812/ijpr-132213
Sry Suryani Widjaja, Imam Bagus Sumantri, Rusdiana Rusdiana, Hendri Yo, Juli Jamnasi, Rudi Yo, Hendrik Kho, Vito Filbert Jayalie, Montesque Silalahi, Fauzie Siregar

Background: The main therapy for head and neck cancer is radiation, and one of the toxic effects of radiation is radiation dermatitis. Aloe vera is a species of succulent plant of the genus Aloe, widely used in cosmetic and skin care products, as well as daikon (Raphanus sativus var. longipinnatus), which is high in antioxidants.

Objectives: The present study aims to evaluate the potential benefits of Aloe vera and daikon gel combination in head and neck cancer patients to prevent radiation-induced dermatitis.

Methods: A cohort study was conducted with eligible subjects, all head and neck cancer patients receiving radiation therapy selected in consecutive sampling. Samples were divided into two groups; either received Aloe vera and daikon combination gel (study group) or baby oil (control induced dermatitis (RID) were observed.

Results: A total of 44 patients were grouped into intervention (Aloe vera-daikon gel) and control (baby oil) groups. After ten radiotherapies (RT) sessions, the intervention group had a lower percentage of grade 1 RID (35% vs. 91.7%, control: 65% grade 2 RID, P < 0.001). After 20 RT sessions, 40% had no dermatitis, while all patients had RID in the control group (P = 0.061). After 30 RT sessions, the intervention group had a lower RID grade overall (gr 0: 5%, gr 1: 85%, gr 2: 10%) compared to the control group (gr 1: 33.3%, gr 2: 54.3%, gr 3: 8.3%, P = 0.002). After 35 RT sessions, the intervention group also had a lower RID grade overall (gr 0: 5%, gr 1: 65%, gr 2: 20%, gr 3: 10%) compared to the control group (gr 1: 8.3%, gr 2: 37.5%, gr 3: 45.8%, gr 4: 8.3%, P < 0.001).

Conclusions: The combination of Aloe vera and daikon gel showed promising results in reducing the severity of radiation-induced dermatitis for head and neck cancer patients.

背景:头颈癌的主要治疗方法是放疗,而放疗的毒性作用之一是放射性皮炎。芦荟是芦荟属的一种多肉植物,广泛用于化妆品和护肤品,还有白萝卜(Raphanus sativus var. longipinnatus),它富含抗氧化剂。目的:本研究旨在评估芦荟和白萝卜凝胶联合使用对头颈癌患者预防放射性皮炎的潜在益处。方法:采用队列研究方法,连续抽样选取所有接受放射治疗的头颈癌患者。样本分为两组;两组分别服用芦荟白萝卜联合凝胶(研究组)和婴儿油(对照组诱发性皮炎)。结果:44例患者分为干预组(芦荟凝胶)和对照组(婴儿油)。10次放疗(RT)后,干预组的1级RID发生率较低(35% vs. 91.7%,对照组:65%,P < 0.001)。20个RT疗程后,40%的患者无皮炎,而对照组所有患者均有RID (P = 0.061)。在30个RT疗程后,干预组的RID评分总体较低(gr 0: 5%, gr 1: 85%, gr 2: 10%),而对照组(gr 1: 33.3%, gr 2: 54.3%, gr 3: 8.3%, P = 0.002)。经过35次RT治疗后,干预组的RID评分总体上也低于对照组(1:8.3%,2:37.5%,2:20%,3:10%)(1:8.3%,2:37.5%,3:45.8%,4:8.3%,P < 0.001)。结论:芦荟与白萝卜凝胶联合用药对降低头颈癌患者放射性皮炎的严重程度有较好的疗效。
{"title":"Potential Benefits of <i>Aloe vera</i> and <i>Raphanus sativus var. longipinnatus</i> Gel for Prevention of Radiation-Induced Dermatitis in Head and Neck Cancer Patients.","authors":"Sry Suryani Widjaja,&nbsp;Imam Bagus Sumantri,&nbsp;Rusdiana Rusdiana,&nbsp;Hendri Yo,&nbsp;Juli Jamnasi,&nbsp;Rudi Yo,&nbsp;Hendrik Kho,&nbsp;Vito Filbert Jayalie,&nbsp;Montesque Silalahi,&nbsp;Fauzie Siregar","doi":"10.5812/ijpr-132213","DOIUrl":"https://doi.org/10.5812/ijpr-132213","url":null,"abstract":"<p><strong>Background: </strong>The main therapy for head and neck cancer is radiation, and one of the toxic effects of radiation is radiation dermatitis. <i>Aloe vera</i> is a species of succulent plant of the genus <i>Aloe</i>, widely used in cosmetic and skin care products, as well as daikon (<i>Raphanus sativus var. longipinnatus</i>), which is high in antioxidants.</p><p><strong>Objectives: </strong>The present study aims to evaluate the potential benefits of <i>Aloe vera</i> and daikon gel combination in head and neck cancer patients to prevent radiation-induced dermatitis.</p><p><strong>Methods: </strong>A cohort study was conducted with eligible subjects, all head and neck cancer patients receiving radiation therapy selected in consecutive sampling. Samples were divided into two groups; either received <i>Aloe vera</i> and daikon combination gel (study group) or baby oil (control induced dermatitis (RID) were observed.</p><p><strong>Results: </strong>A total of 44 patients were grouped into intervention (<i>Aloe vera</i>-daikon gel) and control (baby oil) groups. After ten radiotherapies (RT) sessions, the intervention group had a lower percentage of grade 1 RID (35% vs. 91.7%, control: 65% grade 2 RID, P < 0.001). After 20 RT sessions, 40% had no dermatitis, while all patients had RID in the control group (P = 0.061). After 30 RT sessions, the intervention group had a lower RID grade overall (gr 0: 5%, gr 1: 85%, gr 2: 10%) compared to the control group (gr 1: 33.3%, gr 2: 54.3%, gr 3: 8.3%, P = 0.002). After 35 RT sessions, the intervention group also had a lower RID grade overall (gr 0: 5%, gr 1: 65%, gr 2: 20%, gr 3: 10%) compared to the control group (gr 1: 8.3%, gr 2: 37.5%, gr 3: 45.8%, gr 4: 8.3%, P < 0.001).</p><p><strong>Conclusions: </strong>The combination of <i>Aloe vera</i> and daikon gel showed promising results in reducing the severity of radiation-induced dermatitis for head and neck cancer patients.</p>","PeriodicalId":14595,"journal":{"name":"Iranian Journal of Pharmaceutical Research","volume":"21 1","pages":"e132213"},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/85/1b/ijpr-21-1-132213.PMC9990509.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9454826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Mouse Model of Irritant Contact Dermatitis. 小鼠刺激性接触性皮炎模型。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-12-01 DOI: 10.5812/ijpr-130881
Monireh Malekpour, Atefe Etebari, Mahsa Hezarosi, Ali Anissian, Forouzan Karimi

Background: Irritant contact dermatitis is a common inflammatory skin disease characterized by skin barrier dysfunction, eczematous dermatitis, and chronic itching. This disease severely affects the quality of life. Considering that the current treatment approaches are not ideal, more extensive research is needed to develop new treatments. Mainly, a mouse model is needed to investigate the effectiveness of new drugs to treat this disease.

Objectives: This study was conducted to create a mouse model of irritant contact dermatitis.

Methods: In the current study, we used BALB/c female mice to prepare a mouse model of irritant contact dermatitis. To induce irritant contact dermatitis, we used a dinitrochlorobenzene mixture with acetone/olive oil as an irritant. After 10 days of application, the mouse skin tissue was isolated and examined in terms of histopathology.

Results: The introduced protocol created an irritant contact dermatitis model clinically and histopathologically.

Conclusions: In the present study, we introduced a new protocol using a mixture of dinitrochlorobenzene and acetone/olive oil to create an irritant contact dermatitis model. Mouse models have been extensively used to discover the complex mechanisms of irritant contact dermatitis and provide a preclinical platform before conducting clinical interventional research on humans to evaluate a new therapeutic approach. However, one should always look for models that cause the least pain and suffering in the animal and simultaneously are simple and reliable for the desired studies. Thus, our protocol is a new approach that can be effective and painless in creating a model of irritant contact dermatitis.

背景:刺激性接触性皮炎是一种常见的炎症性皮肤病,以皮肤屏障功能障碍、湿疹性皮炎和慢性瘙痒为特征。这种疾病严重影响生活质量。考虑到目前的治疗方法并不理想,需要更广泛的研究来开发新的治疗方法。主要需要一个小鼠模型来研究新药治疗这种疾病的有效性。目的:建立小鼠刺激性接触性皮炎模型。方法:本研究采用BALB/c雌性小鼠制备小鼠刺激性接触性皮炎模型。为了诱发刺激性接触性皮炎,我们使用了二硝基氯苯与丙酮/橄榄油的混合物作为刺激物。应用10天后,分离小鼠皮肤组织,进行组织病理学检查。结果:引入的方案在临床和组织病理学上建立了一种刺激性接触性皮炎模型。结论:在本研究中,我们引入了一种新的方案,使用二硝基氯苯和丙酮/橄榄油的混合物来创建刺激性接触性皮炎模型。小鼠模型已被广泛用于发现刺激性接触性皮炎的复杂机制,并为开展人体临床介入研究提供临床前平台,以评估新的治疗方法。然而,人们应该总是寻找对动物造成最小痛苦和痛苦的模型,同时对期望的研究来说是简单可靠的。因此,我们的方案是一种新的方法,可以有效和无痛地创建一个模型的刺激性接触性皮炎。
{"title":"Mouse Model of Irritant Contact Dermatitis.","authors":"Monireh Malekpour,&nbsp;Atefe Etebari,&nbsp;Mahsa Hezarosi,&nbsp;Ali Anissian,&nbsp;Forouzan Karimi","doi":"10.5812/ijpr-130881","DOIUrl":"https://doi.org/10.5812/ijpr-130881","url":null,"abstract":"<p><strong>Background: </strong>Irritant contact dermatitis is a common inflammatory skin disease characterized by skin barrier dysfunction, eczematous dermatitis, and chronic itching. This disease severely affects the quality of life. Considering that the current treatment approaches are not ideal, more extensive research is needed to develop new treatments. Mainly, a mouse model is needed to investigate the effectiveness of new drugs to treat this disease.</p><p><strong>Objectives: </strong>This study was conducted to create a mouse model of irritant contact dermatitis.</p><p><strong>Methods: </strong>In the current study, we used BALB/c female mice to prepare a mouse model of irritant contact dermatitis. To induce irritant contact dermatitis, we used a dinitrochlorobenzene mixture with acetone/olive oil as an irritant. After 10 days of application, the mouse skin tissue was isolated and examined in terms of histopathology.</p><p><strong>Results: </strong>The introduced protocol created an irritant contact dermatitis model clinically and histopathologically.</p><p><strong>Conclusions: </strong>In the present study, we introduced a new protocol using a mixture of dinitrochlorobenzene and acetone/olive oil to create an irritant contact dermatitis model. Mouse models have been extensively used to discover the complex mechanisms of irritant contact dermatitis and provide a preclinical platform before conducting clinical interventional research on humans to evaluate a new therapeutic approach. However, one should always look for models that cause the least pain and suffering in the animal and simultaneously are simple and reliable for the desired studies. Thus, our protocol is a new approach that can be effective and painless in creating a model of irritant contact dermatitis.</p>","PeriodicalId":14595,"journal":{"name":"Iranian Journal of Pharmaceutical Research","volume":"21 1","pages":"e130881"},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/84/38/ijpr-21-1-130881.PMC9872550.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10639161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sb(V) Kaempferol and Quercetin Derivative Complexes: Synthesis, Characterization and Antileishmanial Activities. Sb(V)山奈酚和槲皮素衍生物配合物的合成、表征及抗利什曼原虫活性。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-12-01 DOI: 10.5812/ijpr-128379
Sara Abdeyazdan, Maryam Mohajeri, Sedigheh Saberi, Mahmoud Mirzaei, Seyed Abdulmajid Ayatollahi, Lotfollah Saghaei, Mustafa Ghanadian

Background: Recent studies on Leishmaniasis treatment have confirmed the antiparasitic effects of flavonols and organic antimony pentavalent [(Sb(V)] complexes.

Objectives: This study aimed to identify new Sb(V) complexes by combining the benefits of antimonials and flavonols as well as by optimizing their properties.

Methods: Kaempferol and quercetin peracetate were prepared using acetic anhydride in pyridine. By performing regioselective synthesis, 7-O-paramethylbenzyl as an electron-donating group and 7-O-paranitrobenzyl as an electron-withdrawing group were added to quercetin, and, then, the synthesis of Sb(V) kaempferol and quercetin derivative complexes were performed using SbCl5 solution in glacial acetic acid. The structures were confirmed by UV, ESI mass, IR, 1H-, and 13C-NMR spectral data, and the Stoichiometry of the ligand-metal complex by the mole ratio method. Computational molecular modeling was conducted using the Gaussian program.

Results: The structures were confirmed based on the results from UV, nuclear magnetic resonance (NMR), and electrospray ionization (ESI) mass analyses (3-12). Among the produced compounds, 11 and 12 as newly described, and other compounds as pre-defined compounds were identified. According to the results from biological test, kaempferol triacetate with more lipophilicity showed the highest anti-promastigote activity with an IC50 value of 14.93 ± 2.21 µM. As for anti-amastigote activity, despite the differences, all antimony complexes showed anti-amastigote effects in vitro with IC50 values of 0.52 to 14.50 µM.

Conclusions: All flavonol Sb(V) complexes showed higher activity compared to meglumine antimonate in anti-amastigote effect. Inside the host macrophages, by breaking down the complex into antimony and quercetin or kaempferol analogs, the observed antiparasitic effects may have been related to both Sb(V)/Sb(III) conversion and flavonoid antileishmanial activities.

背景:近年来对利什曼病治疗的研究证实了黄酮醇和有机锑五价[(Sb(V))]配合物的抗寄生虫作用。目的:结合锑类化合物和黄酮醇的优点,并对其性质进行优化,寻找新的Sb(V)配合物。方法:采用吡啶乙酸酐制备山奈酚和过乙酸槲皮素。通过区域选择性合成,在槲皮素上加入7- o -参甲基苄基作为供电子基团和7- o -对硝基苄基作为吸电子基团,在冰醋酸中以SbCl5溶液合成Sb(V)山奈酚和槲皮素衍生物配合物。通过紫外、ESI质量、红外、1H-和13C-NMR谱数据对结构进行了确证,并通过摩尔比法对配-金属配合物进行了化学计量。采用高斯程序进行计算分子模拟。结果:通过紫外光谱(UV)、核磁共振(NMR)和电喷雾电离(ESI)质谱分析(3-12)对化合物的结构进行了确证。所得化合物中有11、12个为新描述化合物,其余为预定义化合物。生物学试验结果显示,亲脂性较强的三醋酸山奈酚抗promastigote活性最高,IC50值为14.93±2.21µM。在抗无尾螺旋体活性方面,尽管不同的锑配合物在体外均具有抗无尾螺旋体的作用,IC50值为0.52 ~ 14.50µM。结论:所有黄酮醇Sb(V)配合物的抗马马线虫作用均高于锑酸甲氨胺。在宿主巨噬细胞内,通过将复合物分解成锑和槲皮素或山奈酚类似物,观察到的抗寄生虫作用可能与Sb(V)/Sb(III)转化和类黄酮抗利什曼原虫活性有关。
{"title":"Sb(V) Kaempferol and Quercetin Derivative Complexes: Synthesis, Characterization and Antileishmanial Activities.","authors":"Sara Abdeyazdan,&nbsp;Maryam Mohajeri,&nbsp;Sedigheh Saberi,&nbsp;Mahmoud Mirzaei,&nbsp;Seyed Abdulmajid Ayatollahi,&nbsp;Lotfollah Saghaei,&nbsp;Mustafa Ghanadian","doi":"10.5812/ijpr-128379","DOIUrl":"https://doi.org/10.5812/ijpr-128379","url":null,"abstract":"<p><strong>Background: </strong>Recent studies on Leishmaniasis treatment have confirmed the antiparasitic effects of flavonols and organic antimony pentavalent [(Sb(V)] complexes.</p><p><strong>Objectives: </strong>This study aimed to identify new Sb(V) complexes by combining the benefits of antimonials and flavonols as well as by optimizing their properties.</p><p><strong>Methods: </strong>Kaempferol and quercetin peracetate were prepared using acetic anhydride in pyridine. By performing regioselective synthesis, 7-O-paramethylbenzyl as an electron-donating group and 7-O-paranitrobenzyl as an electron-withdrawing group were added to quercetin, and, then, the synthesis of Sb(V) kaempferol and quercetin derivative complexes were performed using SbCl<sub>5</sub> solution in glacial acetic acid. The structures were confirmed by UV, ESI mass, IR, 1H-, and <sup>13</sup>C-NMR spectral data, and the Stoichiometry of the ligand-metal complex by the mole ratio method. Computational molecular modeling was conducted using the Gaussian program.</p><p><strong>Results: </strong>The structures were confirmed based on the results from UV, nuclear magnetic resonance (NMR), and electrospray ionization (ESI) mass analyses (3-12). Among the produced compounds, 11 and 12 as newly described, and other compounds as pre-defined compounds were identified. According to the results from biological test, kaempferol triacetate with more lipophilicity showed the highest anti-promastigote activity with an IC<sub>50</sub> value of 14.93 ± 2.21 µM. As for anti-amastigote activity, despite the differences, all antimony complexes showed anti-amastigote effects in vitro with IC<sub>50</sub> values of 0.52 to 14.50 µM.</p><p><strong>Conclusions: </strong>All flavonol Sb(V) complexes showed higher activity compared to meglumine antimonate in anti-amastigote effect. Inside the host macrophages, by breaking down the complex into antimony and quercetin or kaempferol analogs, the observed antiparasitic effects may have been related to both Sb(V)/Sb(III) conversion and flavonoid antileishmanial activities.</p>","PeriodicalId":14595,"journal":{"name":"Iranian Journal of Pharmaceutical Research","volume":"21 1","pages":"e128379"},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ae/fb/ijpr-21-1-128379.PMC10024330.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9163586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
CREB1 and PPAR-α/γ Pathways in Hepatic Ischemia/Reperfusion: Route for Curcumin to Hepatoprotection. 肝缺血/再灌注中CREB1和PPAR-α/γ通路:姜黄素保护肝的途径
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-12-01 DOI: 10.5812/ijpr-133779
Enver Ahmet Demir, Okan Tutuk, Hatice Dogan-Gocmen, Duygu Seren Ozyilmaz, Meryem Ilkay Karagul, Mikail Kara, Muhyittin Temiz, Cemil Tumer

Background: Hepatic ischemia/reperfusion injury is a major problem that can exacerbate complications, particularly in liver transplantations.

Objectives: This study aimed to investigate the cellular mechanisms of ischemia/reperfusion injury and hepatoprotection by curcumin.

Methods: Wistar albino rats were divided into four groups as Control, Sham, I/R, and Cur+I/R. Hepatic ischemia/reperfusion was induced in I/R and Cur+I/R animals, the latter of which was also given 50 mg/kg/day of curcumin for 14 days. Liver aminotransferases and the transcription regulators of inflammation (RelA, IκB, PPAR-α, PPAR-γ, CREB1) were examined along with the histological examination.

Results: Hepatic ischemia/reperfusion was found to disrupt hepatic microstructure and downregulate PPAR-α, PPAR-γ, and CREB1 transcripts. Curcumin supplementation in hepatic ischemia/reperfusion recovered the structural organization and promoted the hepatocyte regeneration while increasing expressions of PPARs and CREB1. RelA and IκB were found unaltered, possibly due to the crosstalk between targeted transcripts by ischemia/reperfusion and curcumin.

Conclusions: In sum, PPAR-α/γ and CREB1 were involved in hepatic ischemia/reperfusion and, moreover, were detected to be stimulated by curcumin. PPAR and CREB pathways were found to provide a route to hepatoprotection for curcumin supplementation as evidenced by the microstructural improvement.

背景:肝缺血/再灌注损伤是可加重并发症的主要问题,特别是在肝移植中。目的:探讨姜黄素对缺血再灌注损伤及肝保护的细胞机制。方法:将Wistar白化大鼠分为Control组、Sham组、I/R组、Cur+I/R组。在I/R和Cur+I/R动物中诱导肝脏缺血再灌注,后者也给予50 mg/kg/d姜黄素,持续14 d。在组织学检查的同时,检测肝脏转氨酶和炎症转录调节因子RelA、IκB、PPAR-α、PPAR-γ、CREB1。结果:肝脏缺血/再灌注破坏肝脏微观结构,下调PPAR-α、PPAR-γ和CREB1转录本。在肝缺血再灌注中补充姜黄素恢复了肝组织结构,促进了肝细胞再生,同时增加了PPARs和CREB1的表达。RelA和i - κ b未发生变化,这可能是由于缺血/再灌注与姜黄素靶向转录物之间的串扰。结论:PPAR-α/γ和CREB1参与肝脏缺血再灌注,且姜黄素对PPAR-α/γ和CREB1有刺激作用。微观结构的改善证明,PPAR和CREB途径为姜黄素补充提供了一条肝保护途径。
{"title":"CREB1 and PPAR-α/γ Pathways in Hepatic Ischemia/Reperfusion: Route for Curcumin to Hepatoprotection.","authors":"Enver Ahmet Demir,&nbsp;Okan Tutuk,&nbsp;Hatice Dogan-Gocmen,&nbsp;Duygu Seren Ozyilmaz,&nbsp;Meryem Ilkay Karagul,&nbsp;Mikail Kara,&nbsp;Muhyittin Temiz,&nbsp;Cemil Tumer","doi":"10.5812/ijpr-133779","DOIUrl":"https://doi.org/10.5812/ijpr-133779","url":null,"abstract":"<p><strong>Background: </strong>Hepatic ischemia/reperfusion injury is a major problem that can exacerbate complications, particularly in liver transplantations.</p><p><strong>Objectives: </strong>This study aimed to investigate the cellular mechanisms of ischemia/reperfusion injury and hepatoprotection by curcumin.</p><p><strong>Methods: </strong>Wistar albino rats were divided into four groups as Control, Sham, I/R, and Cur+I/R. Hepatic ischemia/reperfusion was induced in I/R and Cur+I/R animals, the latter of which was also given 50 mg/kg/day of curcumin for 14 days. Liver aminotransferases and the transcription regulators of inflammation (RelA, IκB, PPAR-α, PPAR-γ, CREB1) were examined along with the histological examination.</p><p><strong>Results: </strong>Hepatic ischemia/reperfusion was found to disrupt hepatic microstructure and downregulate PPAR-α, PPAR-γ, and CREB1 transcripts. Curcumin supplementation in hepatic ischemia/reperfusion recovered the structural organization and promoted the hepatocyte regeneration while increasing expressions of PPARs and CREB1. RelA and IκB were found unaltered, possibly due to the crosstalk between targeted transcripts by ischemia/reperfusion and curcumin.</p><p><strong>Conclusions: </strong>In sum, PPAR-α/γ and CREB1 were involved in hepatic ischemia/reperfusion and, moreover, were detected to be stimulated by curcumin. PPAR and CREB pathways were found to provide a route to hepatoprotection for curcumin supplementation as evidenced by the microstructural improvement.</p>","PeriodicalId":14595,"journal":{"name":"Iranian Journal of Pharmaceutical Research","volume":"21 1","pages":"e133779"},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/57/a9/ijpr-21-1-133779.PMC10024335.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9163590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Replacement of Trypsin by Proteases for Medical Applications. 蛋白酶替代胰蛋白酶在医学上的应用。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-12-01 DOI: 10.5812/ijpr-126328
Alireza Matinfar, Mehrouz Dezfulian, Nooshin Haghighipour, Mehran Kurdtabar, Ahmad Ali Pourbabaei

Background: Cell culture has a crucial role in many applications in biotechnology. The production of vaccines, recombinant proteins, tissue engineering, and stem cell therapy all need cell culture. Most of these activities needed adherent cells to move, which should be trypsinized several times until received on a large scale. Although trypsin is manufactured from the bovine or porcine pancreas, the problem of contamination by unwanted animal proteins, unwanted immune reactions, or contamination to pathogen reagents is the main problem.

Objectives: This study investigated microbial proteases as a safe alternative for trypsin replacement in cell culture experiments for the detachment of adherent cells.

Methods: The bacteria were isolated from the leather industry effluent based on their protease enzymes. After sequencing their 16S ribosomal deoxyribonucleic acid, their protease enzymes were purified, and their enzyme activities were assayed. The alteration of enzymatic activities using different substrates and the effect of substrate concentrations on enzyme activities were determined. The purified proteases were evaluated for cell detachment in the L929 fibroblast cells compared to trypsin. The separated cells were cultured again, and cell proliferation was determined by the MTT assay.

Results: The results showed that the isolated bacteria were Bacillus pumilus, Stenotrophomonas sp., Klebsiella aerogenes, Stenotrophomonas maltophilia, and Bacillus licheniformis. Among the isolated bacteria, the highest and the lowest protease activity belonged to Stenotrophomonas sp. and K. aerogenes, with 60.34 and 11.09 U/mL protease activity, respectively. All the isolated microbial proteases successfully affected L929 fibroblast cells' surface proteins and detached the cells. A significant induction in cell proliferation was observed in the cells treated with K. aerogenes protease and B. pumilus protease, respectively (P < 0.05).

Conclusions: The obtained results suggested that microbial proteases can be used as safe and efficient alternatives to trypsin in cell culture in biopharmaceutical applications.

背景:细胞培养在生物技术的许多应用中起着至关重要的作用。疫苗、重组蛋白、组织工程和干细胞治疗的生产都需要细胞培养。大多数这些活动需要贴壁细胞移动,这些细胞应该被胰蛋白酶化几次,直到大规模接受。虽然胰蛋白酶是由牛或猪胰腺制造的,但主要问题是被不需要的动物蛋白、不需要的免疫反应或病原体试剂污染的问题。目的:研究微生物蛋白酶作为胰蛋白酶的安全替代品,在细胞培养实验中用于分离贴壁细胞。方法:从皮革工业废水中分离细菌,根据其蛋白酶进行分离。对其16S核糖体脱氧核糖核酸进行测序,纯化蛋白酶,测定酶活性。测定了不同底物对酶活性的影响以及底物浓度对酶活性的影响。与胰蛋白酶相比,纯化的蛋白酶在L929成纤维细胞中对细胞脱离进行了评估。分离后的细胞再次培养,用MTT法测定细胞增殖情况。结果:分离得到的细菌为矮芽孢杆菌、窄养单胞菌、产气克雷伯菌、嗜麦芽窄养单胞菌和地衣芽孢杆菌。蛋白酶活性最高的是窄养单胞菌,最低的是产气K.,分别为60.34 U/mL和11.09 U/mL。所有分离的微生物蛋白酶都成功地影响了L929成纤维细胞的表面蛋白并使细胞分离。产气梭菌蛋白酶和矮子梭菌蛋白酶对细胞增殖均有显著的诱导作用(P < 0.05)。结论:微生物蛋白酶可作为胰蛋白酶在生物制药细胞培养中的安全、有效的替代品。
{"title":"Replacement of Trypsin by Proteases for Medical Applications.","authors":"Alireza Matinfar,&nbsp;Mehrouz Dezfulian,&nbsp;Nooshin Haghighipour,&nbsp;Mehran Kurdtabar,&nbsp;Ahmad Ali Pourbabaei","doi":"10.5812/ijpr-126328","DOIUrl":"https://doi.org/10.5812/ijpr-126328","url":null,"abstract":"<p><strong>Background: </strong>Cell culture has a crucial role in many applications in biotechnology. The production of vaccines, recombinant proteins, tissue engineering, and stem cell therapy all need cell culture. Most of these activities needed adherent cells to move, which should be trypsinized several times until received on a large scale. Although trypsin is manufactured from the bovine or porcine pancreas, the problem of contamination by unwanted animal proteins, unwanted immune reactions, or contamination to pathogen reagents is the main problem.</p><p><strong>Objectives: </strong>This study investigated microbial proteases as a safe alternative for trypsin replacement in cell culture experiments for the detachment of adherent cells.</p><p><strong>Methods: </strong>The bacteria were isolated from the leather industry effluent based on their protease enzymes. After sequencing their 16S ribosomal deoxyribonucleic acid, their protease enzymes were purified, and their enzyme activities were assayed. The alteration of enzymatic activities using different substrates and the effect of substrate concentrations on enzyme activities were determined. The purified proteases were evaluated for cell detachment in the L929 fibroblast cells compared to trypsin. The separated cells were cultured again, and cell proliferation was determined by the MTT assay.</p><p><strong>Results: </strong>The results showed that the isolated bacteria were <i>Bacillus pumilus</i>, <i>Stenotrophomonas</i> sp., <i>Klebsiella aerogenes</i>, <i>Stenotrophomonas maltophilia</i>, and <i>Bacillus licheniformis</i>. Among the isolated bacteria, the highest and the lowest protease activity belonged to <i>Stenotrophomonas</i> sp. and <i>K. aerogenes</i>, with 60.34 and 11.09 U/mL protease activity, respectively. All the isolated microbial proteases successfully affected L929 fibroblast cells' surface proteins and detached the cells. A significant induction in cell proliferation was observed in the cells treated with <i>K. aerogenes</i> protease and <i>B. pumilus</i> protease, respectively (P < 0.05).</p><p><strong>Conclusions: </strong>The obtained results suggested that microbial proteases can be used as safe and efficient alternatives to trypsin in cell culture in biopharmaceutical applications.</p>","PeriodicalId":14595,"journal":{"name":"Iranian Journal of Pharmaceutical Research","volume":"21 1","pages":"e126328"},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b2/db/ijpr-21-1-126328.PMC10024315.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9163592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
New Fluorescent Nanosensor for Determination of Diazepam Using Molecularly Imprinted Mn-doped ZnS Quantum Dots. 用分子印迹mn掺杂ZnS量子点检测安定的新型荧光纳米传感器。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-12-01 DOI: 10.5812/ijpr-127351
Abdolraouf Samadi-Maybodi, Javad Abbasifar, Mohammad Malekaneh

In this study, molecularly imprinted Mn-doped ZnS quantum dots were used as nanosensors to determine diazepam and its metabolites. Mn-doped ZnS quantum dots (QDs) capped with L-cysteine were prepared using a sodium thiosulfate precursor and characterized by various methods. Methacrylic acid was used as a precursor for the synthesis of MIP Mn-doped ZnS QDs and then used to measure diazepam in various samples. The linear dynamic range, coefficient of determination, and detection limit were found to be 0.3 - 250 µmol/L, 0.989 and 8.78 × 10-2 µmol/L, respectively. The interference studies showed that the prepared nanosensor was selective for diazepam and its metabolites.

在本研究中,利用分子印迹mn掺杂ZnS量子点作为纳米传感器来检测地西泮及其代谢物。以硫代硫酸钠为前驱体制备了l -半胱氨酸包盖的mn掺杂ZnS量子点,并对其进行了表征。以甲基丙烯酸为前驱体合成了MIP掺杂mn的ZnS量子点,并测定了不同样品中的地西泮。线性动态范围为0.3 ~ 250µmol/L,测定系数为0.989,检出限为8.78 × 10-2µmol/L。干扰实验表明,所制备的纳米传感器对地西泮及其代谢物具有选择性。
{"title":"New Fluorescent Nanosensor for Determination of Diazepam Using Molecularly Imprinted Mn-doped ZnS Quantum Dots.","authors":"Abdolraouf Samadi-Maybodi,&nbsp;Javad Abbasifar,&nbsp;Mohammad Malekaneh","doi":"10.5812/ijpr-127351","DOIUrl":"https://doi.org/10.5812/ijpr-127351","url":null,"abstract":"<p><p>In this study, molecularly imprinted Mn-doped ZnS quantum dots were used as nanosensors to determine diazepam and its metabolites. Mn-doped ZnS quantum dots (QDs) capped with L-cysteine were prepared using a sodium thiosulfate precursor and characterized by various methods. Methacrylic acid was used as a precursor for the synthesis of MIP Mn-doped ZnS QDs and then used to measure diazepam in various samples. The linear dynamic range, coefficient of determination, and detection limit were found to be 0.3 - 250 µmol/L, 0.989 and 8.78 × 10<sup>-2</sup> µmol/L, respectively. The interference studies showed that the prepared nanosensor was selective for diazepam and its metabolites.</p>","PeriodicalId":14595,"journal":{"name":"Iranian Journal of Pharmaceutical Research","volume":"21 1","pages":"e127351"},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/90/57/ijpr-21-1-127351.PMC10024321.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9163593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation and Comparison of the Effects of Mature Silkworm (Bombyx mori) and Silkworm Pupae Extracts on Schwann Cell Proliferation and Axon Growth: An In Vitro Study. 家蚕和蚕蛹提取物对雪旺细胞增殖和轴突生长影响的体外评价与比较
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-12-01 DOI: 10.5812/ijpr-133552
Mohammad Hossein Khosropanah, Masoumeh Majidi Zolbin, Abdol-Mohammad Kajbafzadeh, Leili Amani, Ismaeil Harririan, Ashkan Azimzadeh, Touraj Nejatian, Mahdi Alizadeh Vaghsloo, Zahra Hassannejad

Background: Silkworm products were first used by physicians more than 8500 years ago, in the early Neolithic period. In Persian medicine, silkworm extract has several uses for treating and preventing neurological, cardiac, and liver diseases. Mature silkworms (Bombyx mori) and their pupae contain a variety of growth factors and proteins that can be used in many repair processes, including nerve regeneration.

Objectives: The study aimed to evaluate the effects of mature silkworm (Bombyx mori), and silkworm pupae extract on Schwann cell proliferation and axon growth.

Methods: Silkworm (Bombyx mori) and silkworm pupae extracts were prepared. Then, the concentration and type of amino acids and proteins in the extracts were evaluated by Bradford assay, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and liquid chromatograph-mass spectrometer (LC-MS/MS). Also, the regenerative potential of extracts for improving Schwann cell proliferation and axon growth was examined by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay, electron microscopy, and NeuroFilament-200 (NF-200) immunostaining.

Results: According to the results of the Bradford test, the total protein content of pupae extract was almost twice that of mature worm extract. Also, SDS-PAGE analysis revealed numerous proteins and growth factors, such as bombyrin and laminin, in extracts that are involved in the repair of the nervous system. In accordance with Bradford's results, the evaluation of extracts using LC-MS/MS revealed that the number of amino acids in pupae extract was higher than in mature silkworm extract. It was found that the proliferation of Schwann cells at a concentration of 0.25 mg/mL in both extracts was higher than the concentrations of 0.01 and 0.05 mg/mL. When using both extracts on dorsal root ganglion (DRGs), an increase in length and number was observed in axons.

Conclusions: The findings of this study demonstrated that extracts obtained from silkworms, especially pupae, can play an effective role in Schwann cell proliferation and axonal growth, which can be strong evidence for nerve regeneration, and, consequently, repairing peripheral nerve damage.

背景:在8500多年前的新石器时代早期,蚕制品首次被医生使用。在波斯医学中,蚕提取物有多种用途,用于治疗和预防神经、心脏和肝脏疾病。成熟的家蚕及其蛹含有多种生长因子和蛋白质,可用于许多修复过程,包括神经再生。目的:研究家蚕和蚕蛹提取物对雪旺细胞增殖和轴突生长的影响。方法:制备家蚕及蚕蛹提取物。采用Bradford法、十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)和液相色谱-质谱联用仪(LC-MS/MS)测定提取物中氨基酸和蛋白质的浓度和类型。此外,通过3-(4,5 -二甲基噻唑-2-基)- 2,5 -二苯基溴化四氮唑(MTT)测定、电子显微镜和神经纤维-200 (NF-200)免疫染色检测提取物促进雪旺细胞增殖和轴突生长的再生潜力。结果:根据Bradford试验结果,蛹提取物的总蛋白含量几乎是成熟虫提取物的两倍。此外,SDS-PAGE分析显示,在提取物中有许多蛋白质和生长因子,如bombyrin和层粘连蛋白,参与神经系统的修复。根据Bradford的结果,用LC-MS/MS对提取物进行评价,发现蛹提取物中的氨基酸数量高于成熟蚕提取物。结果表明,浓度为0.25 mg/mL的两种提取物对雪旺细胞的增殖作用均高于浓度为0.01和0.05 mg/mL的提取物。两种提取物作用于背根神经节(DRGs)时,轴突的长度和数量均增加。结论:蚕蛹提取物对雪旺细胞增殖和轴突生长具有一定的促进作用,为神经再生和修复周围神经损伤提供了有力的证据。
{"title":"Evaluation and Comparison of the Effects of Mature Silkworm (<i>Bombyx mori</i>) and Silkworm Pupae Extracts on Schwann Cell Proliferation and Axon Growth: An In Vitro Study.","authors":"Mohammad Hossein Khosropanah,&nbsp;Masoumeh Majidi Zolbin,&nbsp;Abdol-Mohammad Kajbafzadeh,&nbsp;Leili Amani,&nbsp;Ismaeil Harririan,&nbsp;Ashkan Azimzadeh,&nbsp;Touraj Nejatian,&nbsp;Mahdi Alizadeh Vaghsloo,&nbsp;Zahra Hassannejad","doi":"10.5812/ijpr-133552","DOIUrl":"https://doi.org/10.5812/ijpr-133552","url":null,"abstract":"<p><strong>Background: </strong>Silkworm products were first used by physicians more than 8500 years ago, in the early Neolithic period. In Persian medicine, silkworm extract has several uses for treating and preventing neurological, cardiac, and liver diseases. Mature silkworms (<i>Bombyx mori</i>) and their pupae contain a variety of growth factors and proteins that can be used in many repair processes, including nerve regeneration.</p><p><strong>Objectives: </strong>The study aimed to evaluate the effects of mature silkworm (<i>Bombyx mori</i>), and silkworm pupae extract on Schwann cell proliferation and axon growth.</p><p><strong>Methods: </strong>Silkworm (<i>Bombyx mori</i>) and silkworm pupae extracts were prepared. Then, the concentration and type of amino acids and proteins in the extracts were evaluated by Bradford assay, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and liquid chromatograph-mass spectrometer (LC-MS/MS). Also, the regenerative potential of extracts for improving Schwann cell proliferation and axon growth was examined by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay, electron microscopy, and NeuroFilament-200 (NF-200) immunostaining.</p><p><strong>Results: </strong>According to the results of the Bradford test, the total protein content of pupae extract was almost twice that of mature worm extract. Also, SDS-PAGE analysis revealed numerous proteins and growth factors, such as bombyrin and laminin, in extracts that are involved in the repair of the nervous system. In accordance with Bradford's results, the evaluation of extracts using LC-MS/MS revealed that the number of amino acids in pupae extract was higher than in mature silkworm extract. It was found that the proliferation of Schwann cells at a concentration of 0.25 mg/mL in both extracts was higher than the concentrations of 0.01 and 0.05 mg/mL. When using both extracts on dorsal root ganglion (DRGs), an increase in length and number was observed in axons.</p><p><strong>Conclusions: </strong>The findings of this study demonstrated that extracts obtained from silkworms, especially pupae, can play an effective role in Schwann cell proliferation and axonal growth, which can be strong evidence for nerve regeneration, and, consequently, repairing peripheral nerve damage.</p>","PeriodicalId":14595,"journal":{"name":"Iranian Journal of Pharmaceutical Research","volume":"21 1","pages":"e133552"},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/15/08/ijpr-21-1-133552.PMC9990520.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9438271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Effects of Ziziphus Jujuba Extract Alone and Combined with Boswellia Serrata Extract on Monosodium Iodoacetate Model of Osteoarthritis in Mice. 酸枣提取物单用及联用对碘乙酸钠骨关节炎模型小鼠的影响。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-12-01 DOI: 10.5812/ijpr-134338
Mona Khoramjouy, Maryam Bayanati, Shokoofe Noori, Mehrdad Faizi, Afshin Zarghi

Background: As a chronic joint condition, osteoarthritis (OA) is a common problem among older people. Pain, aching, stiffness, swelling, decreased flexibility, reduced function, and disability are the symptoms of arthritis.

Objectives: In this study, we tested the extracts of Ziziphus jujuba (ZJE) and Boswellia serrata (BSE) to reduce OA symptoms as an alternative treatment.

Methods: NMRI mice were administered an intra-articular injection of monosodium iodoacetate (MIA; 1 mg/10 mL) in the left knee joint cavity for the induction of OA. Hydroalcoholic extracts of ZJE (250 and 500 mg/kg), BSE (100 and 200 mg/kg), and combined ZJE and BSE were orally administered daily for 21 days. Following behavioral tests, plasma samples were collected to detect inflammatory factors. To screen for general toxicity, acute oral toxicity was evaluated.

Results: Oral administration of all the hydroalcoholic extracts significantly increased the locomotor activity, pixel values of the foot-print area, paw withdrawal threshold, the latency of the withdrawal response to heat stimulation, and decreased the difference between pixel values of hind limbs compared to the vehicle group. Also, the elevated levels of IL-1β, IL-6, and TNF-α were reduced. As tested in this study, ZJE and BSE were practically nontoxic and had a high degree of safety.

Conclusions: This study demonstrated that the oral administration of ZJE and BSE slows the progression of OA through anti-nociceptive and anti-inflammatory properties. Oral co-administration of ZJE and BSE extracts can be used as herbal medicine to inhibit OA progression.

背景:骨关节炎(OA)作为一种慢性关节疾病,是老年人的常见病。疼痛、疼痛、僵硬、肿胀、柔韧性下降、功能下降和残疾是关节炎的症状。目的:在本研究中,我们测试了酸枣(ZJE)和锯齿乳香(BSE)提取物作为替代治疗OA症状的效果。方法:给NMRI小鼠关节内注射碘乙酸钠(MIA);1 mg/10 mL)于左膝关节腔诱导OA。每天口服ZJE(250和500 mg/kg)、BSE(100和200 mg/kg)和ZJE和BSE联合水醇提取物,共21 d。行为测试后,收集血浆样本检测炎症因子。为了筛选一般毒性,评估了急性口服毒性。结果:口服各水酒精提取物均能显著提高大鼠运动活性、足区像素值、足爪戒断阈值、热刺激戒断反应潜伏期,并显著降低后肢像素值与对照组的差异。同时,升高的IL-1β、IL-6和TNF-α水平也有所降低。经本研究检测,ZJE和BSE实际上是无毒的,具有高度的安全性。结论:本研究表明,口服ZJE和BSE通过抗伤害和抗炎特性减缓OA的进展。口服ZJE和BSE提取物可作为抑制OA进展的草药。
{"title":"Effects of <i>Ziziphus Jujuba</i> Extract Alone and Combined with <i>Boswellia Serrata</i> Extract on Monosodium Iodoacetate Model of Osteoarthritis in Mice.","authors":"Mona Khoramjouy,&nbsp;Maryam Bayanati,&nbsp;Shokoofe Noori,&nbsp;Mehrdad Faizi,&nbsp;Afshin Zarghi","doi":"10.5812/ijpr-134338","DOIUrl":"https://doi.org/10.5812/ijpr-134338","url":null,"abstract":"<p><strong>Background: </strong>As a chronic joint condition, osteoarthritis (OA) is a common problem among older people. Pain, aching, stiffness, swelling, decreased flexibility, reduced function, and disability are the symptoms of arthritis.</p><p><strong>Objectives: </strong>In this study, we tested the extracts of <i>Ziziphus jujuba</i> (ZJE) and <i>Boswellia serrata</i> (BSE) to reduce OA symptoms as an alternative treatment.</p><p><strong>Methods: </strong>NMRI mice were administered an intra-articular injection of monosodium iodoacetate (MIA; 1 mg/10 mL) in the left knee joint cavity for the induction of OA. Hydroalcoholic extracts of ZJE (250 and 500 mg/kg), BSE (100 and 200 mg/kg), and combined ZJE and BSE were orally administered daily for 21 days. Following behavioral tests, plasma samples were collected to detect inflammatory factors. To screen for general toxicity, acute oral toxicity was evaluated.</p><p><strong>Results: </strong>Oral administration of all the hydroalcoholic extracts significantly increased the locomotor activity, pixel values of the foot-print area, paw withdrawal threshold, the latency of the withdrawal response to heat stimulation, and decreased the difference between pixel values of hind limbs compared to the vehicle group. Also, the elevated levels of IL-1β, IL-6, and TNF-α were reduced. As tested in this study, ZJE and BSE were practically nontoxic and had a high degree of safety.</p><p><strong>Conclusions: </strong>This study demonstrated that the oral administration of ZJE and BSE slows the progression of OA through anti-nociceptive and anti-inflammatory properties. Oral co-administration of ZJE and BSE extracts can be used as herbal medicine to inhibit OA progression.</p>","PeriodicalId":14595,"journal":{"name":"Iranian Journal of Pharmaceutical Research","volume":"21 1","pages":"e134338"},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/56/a9/ijpr-21-1-134338.PMC9990515.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9454827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Iranian Journal of Pharmaceutical Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1